These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 10674567

  • 21. Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group.
    Johnson PA, Rodriguez HP, Wazen JJ, Huck W, Shan M, Tosiello R, Heyd A, Echols RM.
    J Otolaryngol; 1999 Feb; 28(1):3-12. PubMed ID: 10077777
    [Abstract] [Full Text] [Related]

  • 22. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group.
    Henry DC, Nenad RC, Iravani A, Tice AD, Mansfield DL, Magner DJ, Dorr MB, Talbot GH.
    Clin Ther; 1999 Jun; 21(6):966-81. PubMed ID: 10440621
    [Abstract] [Full Text] [Related]

  • 23. Bacteriological findings and antimicrobial susceptibility in chronic sinusitis with nasal polyp.
    Kim HJ, Lee K, Yoo JB, Song JW, Yoon JH.
    Acta Otolaryngol; 2006 May; 126(5):489-97. PubMed ID: 16698698
    [Abstract] [Full Text] [Related]

  • 24. Bacterial findings in acute maxillary sinusitis--European study.
    Penttilä M, Savolainen S, Kiukaanniemi H, Forsblom B, Jousimies-Somer H.
    Acta Otolaryngol Suppl; 1997 May; 529():165-8. PubMed ID: 9288300
    [Abstract] [Full Text] [Related]

  • 25. Acute rhinosinusitis (ARS). Diagnosis and treatment of adults in general practice.
    Hansen JG.
    Dan Med J; 2014 Feb; 61(2):B4801. PubMed ID: 24495896
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of cefixime in the treatment of bacterial maxillary sinusitis.
    Matthews BL, Kohut RI, Edelstein DR, Rybak LP, Rapp M, McCaffrey TV, Kimmelman CP, Parnes SM, Marinaccio AT, Kohlbrenner VM.
    South Med J; 1993 Mar; 86(3):329-33. PubMed ID: 8451674
    [Abstract] [Full Text] [Related]

  • 27. Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study.
    Leibovitz E, Piglansky L, Raiz S, Greenberg D, Hamed KA, Ledeine JM, Press J, Leiberman A, Echols RM, Pierce PF, Jacobs MR, Dagan R.
    Pediatr Infect Dis J; 2003 Nov; 22(11):943-9. PubMed ID: 14614364
    [Abstract] [Full Text] [Related]

  • 28. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group.
    Siegert R, Gehanno P, Nikolaidis P, Bagger-Sjöbäck D, Ibanez JM, Hampel B, Sommerauer B.
    Respir Med; 2000 Apr; 94(4):337-44. PubMed ID: 10845431
    [Abstract] [Full Text] [Related]

  • 29. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
    Henry DC, Kapral D, Busman TA, Paris MM.
    Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
    [Abstract] [Full Text] [Related]

  • 30. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis.
    Adelglass J, Jones TM, Ruoff G, Kahn JB, Wiesinger BA, Rielly-Gauvin K, Siu CO.
    Pharmacotherapy; 1998 Dec; 18(6):1255-63. PubMed ID: 9855324
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the in vitro activity of and pathogen responses to sparfloxacin with those of other agents in the treatment of respiratory tract, urinary tract, and skin and skin-structure infections.
    Dowzicky M, Nadler H, Dorr MB, Acusta A, Talbot GH.
    Clin Ther; 1999 May; 21(5):790-805; discussion 789. PubMed ID: 10397375
    [Abstract] [Full Text] [Related]

  • 32. [Efficacy and safety of telithromycin in the treatment of acute maxillary sinusitis].
    Dubreuil C, Ebbo D, Goldstein F, Groupe investigateurs.
    Med Mal Infect; 2005 Apr; 35(4):197-204. PubMed ID: 15914288
    [Abstract] [Full Text] [Related]

  • 33. A comparison of the efficacy of telithromycin versus cefuroxime axetil in the treatment of acute bacterial maxillary sinusitis.
    Buchanan PP, Stephens TA, Leroy B.
    Am J Rhinol; 2003 Apr; 17(6):369-77. PubMed ID: 14750614
    [Abstract] [Full Text] [Related]

  • 34. Antimicrobial treatment of sinusitis.
    Bamberger DM.
    Semin Respir Infect; 1991 Jun; 6(2):77-84. PubMed ID: 1771306
    [Abstract] [Full Text] [Related]

  • 35. Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis.
    Ambrose PG, Anon JB, Bhavnani SM, Okusanya OO, Jones RN, Paglia MR, Kahn J, Drusano GL.
    Diagn Microbiol Infect Dis; 2008 May; 61(1):13-20. PubMed ID: 18313879
    [Abstract] [Full Text] [Related]

  • 36. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 37. Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis.
    Anon JB, Paglia M, Xiang J, Ambrose PG, Jones RN, Kahn JB.
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):105-7. PubMed ID: 17178300
    [Abstract] [Full Text] [Related]

  • 38. Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group.
    Gehanno P, Berche P.
    J Antimicrob Chemother; 1996 May; 37 Suppl A():105-14. PubMed ID: 8737130
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of a complex homeopathic medication (Sinfrontal) in patients with acute maxillary sinusitis: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Zabolotnyi DI, Kneis KC, Richardson A, Rettenberger R, Heger M, Kaszkin-Bettag M, Heger PW.
    Explore (NY); 2007 May; 3(2):98-109. PubMed ID: 17362845
    [Abstract] [Full Text] [Related]

  • 40. Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group.
    Henry D, Ellison W, Sullivan J, Mansfield DL, Magner DJ, Dorr MB, Talbot GH.
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2262-6. PubMed ID: 9736546
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.